Amyloid and tau in the brain in sporadic Alzheimer's disease: Defining the chicken and the egg

Acta Neuropathologica

Volumn 127, Issue 4, 2014, Pages 617-618

  Hawkes, Cheryl A ^a   Carare, Roxana O ^a   Weller, Roy O ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; FIBRILLAR AMYLOID; MEMBRANE METALLOENDOPEPTIDASE; TAU PROTEIN; UNCLASSIFIED DRUG;

ABSORPTION; AGE; ALLELE; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTERIAL STIFFNESS; ARTERY WALL; BASEMENT MEMBRANE; BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN FUNCTION; BRAIN LEVEL; DEMENTIA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; LETTER; LEUKOARAIOSIS; LYMPHATIC DRAINAGE; NEUROPATHOLOGY; NONHUMAN; PERIVASCULAR DRAINAGE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN TRANSPORT; PULSE WAVE; SPORADIC ALZHEIMER DISEASE; VASCULAR AMYLOIDOSIS; WHITE MATTER;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID; BRAIN; HUMANS; NEURONS; TAU PROTEINS;

EID: 84896549213     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1243-9     Document Type: Letter

References (19)

1. Arbel-Ornath M, Hudry E, Eikermann-Haerter K, Hou S, Gregory JL, Zhao L, Betensky RA, Frosch MP, Greenberg SM, Bacskai BJ (2013) Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol 126(3):353-364. doi:10.1007/s00401-013-1145-2
2. Attems J, Jellinger KA (2013) Amyloid and tau: neither chicken nor egg but two partners in crime! Acta Neuropathol 126(4):619-621. doi:10.1007/s00401- 013-1167-9
3. Braak H, Del Tredici K (2013) Reply: the early pathological process in sporadic Alzheimer's disease. Acta Neuropathol 126(4):615-618. doi:10.1007/s00401-013-1170-1
4. Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JAR, Perry VH, Weller RO (2008) Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries. Significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 34:131-144 (Pubitemid 351327967)
5. Carare RO, Hawkes CA, Jeffrey M, Kalaria RN, Weller RO (2013) Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol Appl Neurobiol 39(6):593-611. doi:10.1111/nan.12042
6. CFAS NGoM (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357:169-175
7. Hawkes CA, Hartig W, Kacza J, Schliebs R, Weller RO, Nicoll JA, Carare RO (2011) Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol 121:431-443. doi:10.1007/s00401-011-0801-7
8. Hawkes CA, Sullivan PM, Hands S, Weller RO, Nicoll JA, Carare RO (2012) Disruption of arterial perivascular drainage of amyloid-beta from the brains of mice expressing the human APOE epsilon4 allele. PLoS ONE 7(7):e41636. doi:10.1371/journal.pone.0041636
9. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155(3):853-862 (Pubitemid 29426831)
10. Mann DM, Hardy J (2013) Amyloid or tau: the chicken or the egg? Acta Neuropathol 126(4):609-613. doi:10.1007/s00401-013-1162-1
11. Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG (2006) Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol 65:1012-1021 (Pubitemid 44521802)
12. Roher AE, Kuo Y-M, Esh C, Knebel C, Weiss N, Kalback W, Luehrs DC, Childress JL, Beach TG, Weller RO, Kokjohn TA (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 9:112-122 (Pubitemid 36819967)
13. Sagare AP, Bell RD, Zlokovic BV (2012) Neurovascular dysfunction and faulty amyloid beta-peptide clearance in Alzheimer disease. Cold Spring Harbor Perspect Med 2(10). doi:10.1101/cshperspect.a011452
14. Schley D, Carare-Nnadi R, Please CP, Perry VH, Weller RO (2006) Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol 238:962-974 (Pubitemid 43175842)
15. van Helmond Z, Miners JS, Kehoe PG, Love S (2010) Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy. Brain Pathol 20(2):468-480. doi:10.1111/j.1750-3639.2009.00321.x
16. Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 118:87-102
17. Weller RO, Djuanda E, Yow HY, Carare RO (2009) Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 117:1-14
18. Xu W, Xu F, Anderson ME, Kotarba AE, Davis J, Robinson JK, Van Nostrand WE (2014) Cerebral microvascular rather than parenchymal amyloid-beta protein pathology promotes early cognitive impairment in transgenic mice. J Alzheimer's Disease 38(3):621-632. doi:10.3233/JAD-130758
19. Zlokovic BV (2004) Clearing amyloid through the blood-brain barrier. J Neurochem 89:807-811